1 | induction | 12,239 |
2 | consolidation | 934 |
3 | inductions | 90 |
4 | reinduction | 43 |
5 | inducement | 30 |
6 | inductor | 21 |
7 | co-infusion | 14 |
8 | re-induction | 10 |
9 | 18min | 8 |
10 | n-alkylation | 8 |
11 | playback | 8 |
12 | 48weeks | 5 |
13 | 20weeks | 4 |
14 | acupoint-application | 4 |
15 | begining | 4 |
16 | decellularisation | 4 |
17 | dolorosa | 4 |
18 | lexicalization | 4 |
19 | thawing/warming | 4 |
20 | volatilisation | 4 |
21 | 120days | 3 |
22 | 2-doses | 3 |
23 | co-deposition | 3 |
24 | estradiol-treatment | 3 |
25 | intensivity | 3 |
26 | l-vnio | 3 |
27 | n-substituent | 3 |
28 | sasung | 3 |
29 | trans-activation | 3 |
30 | induction/augmentation | 2 |
31 | insulin-therapy | 2 |
32 | maintaince | 2 |
33 | phosphitylation | 2 |
34 | 10,000units/kg | 1 |
35 | 10,552 | 1 |
36 | 150g/d | 1 |
37 | 15g/day | 1 |
38 | 200,000iu | 1 |
39 | 21-day-cycle | 1 |
40 | 27-28th | 1 |
41 | 8.9±2.2yrs | 1 |
42 | 8g/l | 1 |
43 | 8mg/iv | 1 |
44 | adyuvant | 1 |
45 | and/rupture | 1 |
46 | chamberfilled | 1 |
47 | clampiing | 1 |
48 | copyrolysis | 1 |
49 | cross-taper | 1 |
50 | cryo-freezing | 1 |
51 | desflurane-remifentanil-oxygen | 1 |
52 | eeg-electrodes | 1 |
53 | eombined | 1 |
54 | iii-recommended | 1 |
55 | induetion | 1 |
56 | manipulation-extraction | 1 |
57 | mono-medication | 1 |
58 | over-extension | 1 |
59 | re-debridement | 1 |
60 | spme-analysis | 1 |
61 | sub-group.overall | 1 |
1 | 10,000units/kg | 1 |
2 | 10,552 | 1 |
3 | 120days | 3 |
4 | 150g/d | 1 |
5 | 15g/day | 1 |
6 | 18min | 8 |
7 | 2-doses | 3 |
8 | 200,000iu | 1 |
9 | 20weeks | 4 |
10 | 21-day-cycle | 1 |
11 | 27-28th | 1 |
12 | 48weeks | 5 |
13 | 8.9±2.2yrs | 1 |
14 | 8g/l | 1 |
15 | 8mg/iv | 1 |
16 | acupoint-application | 4 |
17 | adyuvant | 1 |
18 | and/rupture | 1 |
19 | begining | 4 |
20 | chamberfilled | 1 |
21 | clampiing | 1 |
22 | co-deposition | 3 |
23 | co-infusion | 14 |
24 | consolidation | 934 |
25 | copyrolysis | 1 |
26 | cross-taper | 1 |
27 | cryo-freezing | 1 |
28 | decellularisation | 4 |
29 | desflurane-remifentanil-oxygen | 1 |
30 | dolorosa | 4 |
31 | eeg-electrodes | 1 |
32 | eombined | 1 |
33 | estradiol-treatment | 3 |
34 | iii-recommended | 1 |
35 | inducement | 30 |
36 | induction | 12,239 |
37 | induction/augmentation | 2 |
38 | inductions | 90 |
39 | inductor | 21 |
40 | induetion | 1 |
41 | insulin-therapy | 2 |
42 | intensivity | 3 |
43 | l-vnio | 3 |
44 | lexicalization | 4 |
45 | maintaince | 2 |
46 | manipulation-extraction | 1 |
47 | mono-medication | 1 |
48 | n-alkylation | 8 |
49 | n-substituent | 3 |
50 | over-extension | 1 |
51 | phosphitylation | 2 |
52 | playback | 8 |
53 | re-debridement | 1 |
54 | re-induction | 10 |
55 | reinduction | 43 |
56 | sasung | 3 |
57 | spme-analysis | 1 |
58 | sub-group.overall | 1 |
59 | thawing/warming | 4 |
60 | trans-activation | 3 |
61 | volatilisation | 4 |
1 | 10,552 | 1 |
2 | dolorosa | 4 |
3 | 150g/d | 1 |
4 | iii-recommended | 1 |
5 | chamberfilled | 1 |
6 | eombined | 1 |
7 | maintaince | 2 |
8 | 21-day-cycle | 1 |
9 | and/rupture | 1 |
10 | 10,000units/kg | 1 |
11 | clampiing | 1 |
12 | thawing/warming | 4 |
13 | begining | 4 |
14 | cryo-freezing | 1 |
15 | sasung | 3 |
16 | 27-28th | 1 |
17 | playback | 8 |
18 | 8g/l | 1 |
19 | sub-group.overall | 1 |
20 | desflurane-remifentanil-oxygen | 1 |
21 | 18min | 8 |
22 | over-extension | 1 |
23 | co-infusion | 14 |
24 | mono-medication | 1 |
25 | acupoint-application | 4 |
26 | consolidation | 934 |
27 | n-alkylation | 8 |
28 | phosphitylation | 2 |
29 | volatilisation | 4 |
30 | decellularisation | 4 |
31 | induction/augmentation | 2 |
32 | trans-activation | 3 |
33 | lexicalization | 4 |
34 | manipulation-extraction | 1 |
35 | induction | 12,239 |
36 | re-induction | 10 |
37 | reinduction | 43 |
38 | induetion | 1 |
39 | co-deposition | 3 |
40 | l-vnio | 3 |
41 | cross-taper | 1 |
42 | inductor | 21 |
43 | eeg-electrodes | 1 |
44 | 2-doses | 3 |
45 | spme-analysis | 1 |
46 | copyrolysis | 1 |
47 | 20weeks | 4 |
48 | 48weeks | 5 |
49 | inductions | 90 |
50 | 8.9±2.2yrs | 1 |
51 | 120days | 3 |
52 | adyuvant | 1 |
53 | inducement | 30 |
54 | re-debridement | 1 |
55 | estradiol-treatment | 3 |
56 | n-substituent | 3 |
57 | 200,000iu | 1 |
58 | 8mg/iv | 1 |
59 | 15g/day | 1 |
60 | insulin-therapy | 2 |
61 | intensivity | 3 |